BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Taspoglutide’s Benefits Similar to Exenatide’s in Patients With Type 2 Diabetes: Dallas Diabetes and Endocrine Center Study Presented at Obesity 2010

  October 12, 2010

   · 

  1 min read
• No CV Benefit Seen With Folic Acid, Oxford University Study

  October 12, 2010

   · 

  1 min read
• BioMidwest

  SynCardia Systems, Inc. Total Artificial Heart Provides ‘Unexpected’ 1,000 Days of Life

  October 12, 2010

   · 

  1 min read
• BioForest

  Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival, British Columbia Cancer Agency and Collaborators Study Find

  October 12, 2010

   · 

  1 min read
• Researchers Investigate ‘Friendly Bacteria’ to Kill Bone Cancer Cells, University of Nottingham Study

  October 12, 2010

   · 

  1 min read
• Erlotinib Trumps Chemo in Advanced NSCLC With EGFR Mutations, Tongji University Study

  October 12, 2010

   · 

  1 min read
• Pharm Country

  Study Analyzes Short- and Long-Term Risks of Carotid Procedures, New York University Study

  October 12, 2010

   · 

  1 min read
• Drug Development

  Too Much Light at Night May Lead To Obesity, Ohio State University Study Finds

  October 12, 2010

   · 

  1 min read
• ESMO: IPASS Data Show No Survival Benefit for Gefitinib, National Taiwan University Hospital Study

  October 12, 2010

   · 

  1 min read
• Drug Development

  Geron Corporation’s First Human Embryonic Stem Cell Trial at Shepherd Center

  October 12, 2010

   · 

  1 min read